Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Docetaxel and Gemcitabine in Advanced Sarcoma
NCT00807261Phase 2Unknown
- Sponsor
- Asan Medical Center
- Start
- Sep 2008
- Primary completion
- Sep 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of docetaxel, gemcitabine in soft tissue sarcoma (STS), bone sarcoma, sponsored by Asan Medical Center. Status: unknown.
02
Drugs
docetaxelgemcitabine
03
Conditions
soft tissue sarcoma (STS)bone sarcoma
Beyond the preview
Go deeper on NCT00807261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00807261.